Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue
Read more
Verify All Oil Trade Documents
Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue
Read moreIn this article BMY Follow your favorite stocksCREATE FREE ACCOUNT FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge,
Read more